Works matching IS 00071048 AND DT 2013 AND VI 160 AND IP 6

Results: 22

Corrigendum.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 868, doi. 10.1111/bjh.12232
Publication type:
Article
Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 825, doi. 10.1111/bjh.12214
By:
- Hing, Zachary A.;
- Schiller, Tal;
- Wu, Andrew;
- Hamasaki‐Katagiri, Nobuko;
- Struble, Evi Budo;
- Russek‐Cohen, Estelle;
- Kimchi‐Sarfaty, Chava
Publication type:
Article
Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 851, doi. 10.1111/bjh.12162
By:
- Yan, Qingguo;
- Wang, Ming;
- Moody, Sarah;
- Xue, Xuemin;
- Huang, Yuanxue;
- Bi, Yingwen;
- Du, Ming‐Qing
Publication type:
Article
Neutrophil-specific granule deficiency.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 735, doi. 10.1111/bjh.12207
By:
- McIlwaine, Louisa;
- Parker, Anne;
- Sandilands, Gavin;
- Gallipoli, Paolo;
- Leach, Mike
Publication type:
Article
Normal prothrombin time in the presence of therapeutic levels of rivaroxaban.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 859, doi. 10.1111/bjh.12173
By:
- Veen, Joost J.;
- Smith, Julie;
- Kitchen, Steve;
- Makris, Mike
Publication type:
Article
Haemorrhage and amyloidosis.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 854, doi. 10.1111/bjh.12166
By:
- Veneri, Dino;
- Pizzolo, Giovanni;
- Bonalumi, Angela;
- Franchini, Massimo
Publication type:
Article
How I manage priapism due to sickle cell disease.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 754, doi. 10.1111/bjh.12199
By:
- Olujohungbe, Ade;
- Burnett, Arthur L.
Publication type:
Article
Multiple cytokine- and chemokine-producing T-cell/histiocyte-rich large B-cell lymphoma.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 734, doi. 10.1111/bjh.12190
By:
- Nakayama, Shoko;
- Yokote, Taiji;
- Hirata, Yuji;
- Iwaki, Kazuki;
- Tsuji, Motomu;
- Hanafusa, Toshiaki
Publication type:
Article
Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 838, doi. 10.1111/bjh.12132
By:
- El‐Galaly, Tarec C.;
- Severinsen, Marianne T.;
- Overvad, Kim;
- Steffensen, Rudi;
- Vistisen, Anders K.;
- Tjønneland, Anne;
- Kristensen, Søren R.
Publication type:
Article
Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 842, doi. 10.1111/bjh.12217
By:
- Davies, Carwyn;
- Yip, Bon Ham;
- Fernandez‐Mercado, Marta;
- Woll, Petter S.;
- Agirre, Xabier;
- Prosper, Felipe;
- Jacobsen, Sten E.;
- Wainscoat, James S.;
- Pellagatti, Andrea;
- Boultwood, Jacqueline
Publication type:
Article
Next-generation sequencing - feasibility and practicality in haematology.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 736, doi. 10.1111/bjh.12194
By:
- Kohlmann, Alexander;
- Grossmann, Vera;
- Nadarajah, Niroshan;
- Haferlach, Torsten
Publication type:
Article
Haemorrhage and amyloidosis - response to Veneri et al.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 854, doi. 10.1111/bjh.12165
By:
- Wettlé, Caroline;
- Springinsfeld, Géraldine;
- Lipsker, Dan
Publication type:
Article
MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 785, doi. 10.1111/bjh.12205
By:
- Sison, Edward Allan R.;
- Rau, Rachel E.;
- McIntyre, Emily;
- Li, Li;
- Small, Donald;
- Brown, Patrick
Publication type:
Article
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 779, doi. 10.1111/bjh.12175
By:
- Hebron, Ellen;
- Hope, Chelsea;
- Kim, Jaehyup;
- Jensen, Jeffrey L.;
- Flanagan, Claire;
- Bhatia, Neehar;
- Maroulakou, Ioanna;
- Mitsiades, Constantine;
- Miyamoto, Shigeki;
- Callander, Natalie;
- Hematti, Peiman;
- Asimakopoulos, Fotis
Publication type:
Article
Identification of novel polymorphism restricted to the (C)ce s type 1 haplotype avoids risk of transfusion deadlock in SCD patients.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 863, doi. 10.1111/bjh.12179
By:
- Silvy, Monique;
- Granier, Thomas;
- Beley, Sophie;
- Chiaroni, Jacques;
- Bailly, Pascal
Publication type:
Article
The actin-binding protein CORO1A is a novel PU.1 ( SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 855, doi. 10.1111/bjh.12170
By:
- Federzoni, Elena A.;
- Humbert, Magali;
- Valk, Peter J. M.;
- Behre, Gerhard;
- Leibundgut, Elisabeth O.;
- Torbett, Bruce E.;
- Fey, Martin F.;
- Tschan, Mario P.
Publication type:
Article
Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 817, doi. 10.1111/bjh.12192
By:
- Roberts, Lara N.;
- Patel, Raj K.;
- Chitongo, Paradzai B.;
- Bonner, Lynda;
- Arya, Roopen
Publication type:
Article
Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 725, doi. 10.1111/bjh.12219
By:
- Dyer, Martin J. S.;
- Vogler, Meike;
- Samuel, Jesvin;
- Jayne, Sandrine;
- Wagner, Simon;
- Pritchard, Catrin;
- Macip, Salvador
Publication type:
Article
Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 766, doi. 10.1111/bjh.12196
By:
- Pessina, Augusto;
- Coccè, Valentina;
- Pascucci, Luisa;
- Bonomi, Arianna;
- Cavicchini, Loredana;
- Sisto, Francesca;
- Ferrari, Maura;
- Ciusani, Emilio;
- Crovace, Antonio;
- Falchetti, Maria Laura;
- Zicari, Sonia;
- Caruso, Arnaldo;
- Navone, Stefania;
- Marfia, Giovanni;
- Benetti, Anna;
- Ceccarelli, Piero;
- Parati, Eugenio;
- Alessandri, Giulio
Publication type:
Article
Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (Hi DAC) based induction chemotherapy.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 861, doi. 10.1111/bjh.12178
By:
- Ling, Victoria;
- Burnett, Alan K.;
- Bradstock, Ken;
- Seymour, John F.;
- Hills, Robert K.;
- Wei, Andrew
Publication type:
Article
A fibrinogen concentrate Haemocomplettan® (Riastap®) or a Factor XIII concentrate Fibrogammin® combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 806, doi. 10.1111/bjh.12189
By:
- He, Shu;
- Johnsson, Hans;
- Zabczyk, Michal;
- Hultenby, Kjell;
- Cao, Honglie;
- Blombäck, Margareta
Publication type:
Article
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
Published in:
British Journal of Haematology, 2013, v. 160, n. 6, p. 798, doi. 10.1111/bjh.12210
By:
- Aung, Fleur M.;
- Lichtiger, Benjamin;
- Bassett, Roland;
- Liu, Ping;
- Alousi, Amin;
- Bashier, Qaiser;
- Ciurea, Stefan O.;
- Lima, Marcos J.;
- Hosing, Chitra;
- Kebriaei, Partow;
- Nieto, Yago;
- Oran, Betul;
- Parmar, Simrit;
- Qazilbash, Muzaffar;
- Shah, Nina;
- Khouri, Issa;
- Champlin, Richard E.;
- Popat, Uday
Publication type:
Article

Works matching IS 00071048 AND DT 2013 AND VI 160 AND IP 6

Corrigendum.

Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.

Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma.

Neutrophil-specific granule deficiency.

Normal prothrombin time in the presence of therapeutic levels of rivaroxaban.

Haemorrhage and amyloidosis.

How I manage priapism due to sickle cell disease.

Multiple cytokine- and chemokine-producing T-cell/histiocyte-rich large B-cell lymphoma.

Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study.

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34<sup>+</sup> progenitor cells.

Next-generation sequencing - feasibility and practicality in haematology.

Haemorrhage and amyloidosis - response to Veneri et al.

MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.

MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.

Identification of novel polymorphism restricted to the (C)ce<sup> s</sup> type 1 haplotype avoids risk of transfusion deadlock in SCD patients.

The actin-binding protein CORO1A is a novel PU.1 ( SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.

Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis.

Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.

Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.

Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (Hi DAC) based induction chemotherapy.

A fibrinogen concentrate Haemocomplettan<sup>®</sup> (Riastap<sup>®</sup>) or a Factor XIII concentrate Fibrogammin<sup>®</sup> combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.